It’s the end of an era—eFFECTOR Therapeutics’ era to be exact. The oncology biotech has laid off staff as it plans to wind down, according to a June 24 company release. This includes eFFECTOR CEO ...
Pfizer has teamed up with Effector Therapeutics to develop small molecule inhibitors of eukaryotic initiation factor 4E (eIF4E). Effector is set to receive $15 million upfront to work on drugs against ...
Pfizer is striking a deal with Effector Therapeutics, a San Diego–based startup that’s developing small-molecule drugs to inhibit hyperactive translation in tumors. The big pharma firm will pay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback